Atrion (ATRI) - EV/EBITDA Multiple

Atrion Corporation Inc. - graphic logo of issuer ATRI

Atrion Corporation (ATRI) is expanding OEM collaborations with leading suppliers to develop custom systems for ophthalmology and fluid infusion. The brand is implementing ESG environmental standards by minimizing toxic plastics and waste. The business's stability is guaranteed by the humanitarian status of its products, which shields the company from geopolitical shocks. This EV/EBITDA chart on GURU.Markets captured a value of , visualizing the market valuation of this medtech manufacturer.

ATRI Atrion Corp: Enterprise Value to Operating Income Before Depreciation in the range 07/04/2022 - 11/13/2026

Analytical breakdowns for atrioncorp.com (ATRI)

- stock price and consensus target price:
Stock Quotes Atrion Corp|ATRI - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Atrion Corporation Inc.|ATRI - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Atrion|ATRI - Accounting Capitalization|Market Value to Book Value Ratio atrioncorp.com|ATRI - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio Atrion Corporation|ATRI - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Atrion|ATRI - Aggregate Debt Obligations|Debt to Book Value Atrion Corporation Inc.|ATRI - Company Long-Term Debts|Company Short-Term Debt Atrion|Quick Ratio atrioncorp.com
- business earnings and investment ratios data:
ATRI - Company Net Income|Expected Profit Atrion Corporation|ATRI - Price to Earnings Multiple|Projected Price to Earnings Atrion Corporation|ATRI - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atrion Corporation Inc.|ATRI - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Atrion|ATRI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months atrioncorp.com|ATRI - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Atrion Corporation
- sales and revenue indicators:
ATRI - Company Sales Revenue|Projected Sales Volume Atrion Corp
Summary company analysis:Atrion Corp (ATRI)
Manufactured products of Atrion

This indicator determines the total business value by combining market capitalization and net debt, divided by operating profit before depreciation. By analyzing the Enterprise Value to EBITDA multiple, an investor separates real production efficiency from the impact of taxes and loans. For the conservative Atrion Corporation (ATRI), with its capital-intensive engineering and social security costs for technical staff, this metric confirms the resilience of its fundamental assets.

Competitors of Atrion Corporation

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|UTMD: EV/EBITDA Multiple|KORU Medical (KRMD) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio NYXH|MBOT (microbotmedical.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pro-Dex (PDEX)|ZTEK (Zentek Ltd) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ELUT (Elutia Corp)|Total Company Value to Operating Income Before Depreciation Ratio Milestone Scientific Corporation (MLSS)|NXGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Retractable Technologies|Harvard Bioscience (HBIO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation FEMY|Enterprise Value to EBITDA Ratio MHUA|POAI: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple CJMB|Enterprise Value to EBITDA Ratio neurometrix.com NURO